G01N 33/5044
Involving specific cell types
Official title: {involving specific cell types}
G01N33/5044 (Involving specific cell types) appears on 4,100 US grants and 8,410 published applications in this corpus.
Search patents in G01N- Granted patents
- 4,100
- Published applications
- 8,410
- Assignees
- 2,741
- Inventors
- 14,317
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 2 | 0 |
| 1992 | 1 | 0 |
| 1993 | 2 | 0 |
| 1994 | 0 | 0 |
| 1995 | 2 | 0 |
| 1996 | 11 | 0 |
| 1997 | 20 | 0 |
| 1998 | 58 | 0 |
| 1999 | 66 | 0 |
| 2000 | 47 | 0 |
| 2001 | 58 | 25 |
| 2002 | 70 | 157 |
| 2003 | 63 | 660 |
| 2004 | 50 | 266 |
| 2005 | 56 | 267 |
| 2006 | 108 | 257 |
| 2007 | 138 | 288 |
| 2008 | 147 | 245 |
| 2009 | 102 | 284 |
| 2010 | 154 | 305 |
| 2011 | 125 | 280 |
| 2012 | 144 | 314 |
| 2013 | 143 | 293 |
| 2014 | 164 | 327 |
| 2015 | 173 | 386 |
| 2016 | 196 | 422 |
| 2017 | 212 | 411 |
| 2018 | 236 | 393 |
| 2019 | 232 | 366 |
| 2020 | 258 | 428 |
| 2021 | 211 | 446 |
| 2022 | 186 | 400 |
| 2023 | 185 | 337 |
| 2024 | 190 | 367 |
| 2025 | 169 | 292 |
| 2026 | 120 | 194 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Single-cell morphology analysis for disease profiling and drug discovery6 Oct 2026US 12,755,831 B2Universität Heidelberg
- FOXM1-derived peptide, and vaccine including same29 Sep 2026US 12,747,265 B2Oncotherapy Science, Inc.
- Complex microfluidic models for ALS including NF biomarkers for ALS research and drug development29 Sep 2026US 12,748,102 B2Cedars-Sinai Medical Center
- Three-dimensional human neural tissues for CRISPR-mediated perturbation of disease genes15 Sep 2026US 12,736,526 B2Massachusetts Institutes of Technology
- Functional cortical organoids, methods of making, and uses thereof15 Sep 2026US 12,736,527 B2The Regents of the University of California
- Composition for inducing immunotolerance8 Oct 2026US 2026/0306540 A1
- Targeted Immune Cell Therapy Utilizing TRAIL and TNF Mediated Apoptosis8 Oct 2026US 2026/0306542 A1Northeastern University
- Prediction of immunostimulatory potential of aav in a human preclinical model8 Oct 2026US 2026/0309699 A1
- Ligand discovery and gene delivery via retroviral surface display8 Oct 2026US 2026/0309700 A1Massachusetts Institute of Technology
- Compositions and methods for determining the effects of t cell engager8 Oct 2026US 2026/0309708 A1Arbele Limited
Most cited
By later US patents
- High throughput screening assay systems in microscale fluidic devices877US 5,942,443 ACaliper Technologies Corp. · 1999
- High throughput screening assay systems in microscale fluidic devices692US 6,046,056 ACaliper Technologies Corp. · 2000
- High throughput screening assay systems in microscale fluidic devices353US 6,267,858 B1Caliper Technologies Corp. · 2001
- Vascularized perfused microtissue/micro-organ arrays324US 6,197,575 B1Massachusetts Institute of Technology · 2001
- In vitro growth and proliferation of genetically modified multipotent neural stem cells and their progeny316US 5,750,376 ANeurospheres Holdings Ltd. · 1998